Fingerprint
Dive into the research topics of 'Review: In type 2 diabetes, SGLT-2 inhibitors or GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Aoife M. Egan, Victor M. Montori
Research output: Contribution to journal › Comment/debate › peer-review